|Articles|May 25, 2018

Osteoporosis Drug Approval Highlights AJPB Week in Review

Author(s)AJPB staff

Top news of the week from The American Journal of Pharmacy Benefits.

5. FDA Grants Breakthrough Therapy, Fast Track Designations to Narcolepsy Treatment

The FDA has granted Harmony Biosciences a Breakthrough Therapy designation for pitolisant, an investigational therapy for the treatment of cataplexy in patients with narcolepsy.


Latest CME